相关实验视频

Updated: Jun 11, 2025

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

在SGIP1中,一种候选功能丧失变异会导致突触功能障碍和衰退性帕金森症

Marianna Decet¹, Patrick Scott², Sabine Kuenen¹

¹VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium; KU Leuven, Department of Neurosciences, Leuven Brain Institute, 3000 Leuven, Belgium.

Cell reports. Medicine

|September 27, 2024

概括

在SH3GL2交互蛋白1 (SGIP1) 基因的新奇突变与早期发病的帕金森症和认知缺陷有关. 这一发现突出显示了回归性帕金森症的一种形式的突触蛋白质稳定缺陷.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
分子生物学分子生物学

背景情况:

突触功能障碍是帕金森症的早期病理事件.
突触蛋白中的遗传突变与帕金森病的风险增加或引起相关.
了解帕金森症的遗传基础对于开发向疗法至关重要.

研究的目的:

为了确定早期发病的帕金森病的遗传原因在一个血缘关系的阿拉伯家庭.
在体外和体内研究发现突变的功能后果.
探索潜在的分子机制,专注于突触功能和蛋白质稳定.

主要方法:

基因分析以确定受影响家庭成员的突变.
蛋白质功能测试用于评估SGIP1突变的影响.
创建和分析Drosophila melanogaster模型以研究运动,突触传播和神经退行.
用[18F]-化氧葡萄糖进行正子发射断层扫描 (PET) 图像成像,用于代谢网络分析.
组织学和相关光和电子显微镜检查突触结构.

主要成果:

在一个患有早期帕金森症和智力功能障碍的家庭中,确定了SGIP1基因的候选致病突变.
SGIP1突变导致蛋白质功能丧失.
德洛索菲拉模型表现出运动缺陷,突触传输受损,多巴胺突触损失和神经退行.
观察到没有突触多胞体和降解性有机体的积累.
代谢网络分析显示了与异常性帕金森病类似的模式.

结论:

这项研究确定了一种由SGIP1突变引起的新型衰退性帕金森症.
这些发现意味着缺陷的突触蛋白质稳定是这种形式的帕金森症的关键机制.
这项研究为诊断,遗传咨询和相关疾病的潜在治疗开辟了新的可能性.

关键词:

在SGIP1变体中,SGIP1变体是SGIP1.多面体的身体.发作发作这些突触蛋白质稳定酶 (Synaptic Proteostasis) 是一种突触蛋白质稳定酶.年轻发病的帕金森症.

更多相关视频

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Pleiotropy

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...